About Anaptysbio (ANAB)
AnaptysBio, Inc. is a clinical stage biotechnology company. The Company is developing immunology therapeutic product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. It develops its ... Read more
- USD19.61
- USD20.66
- USD19.08
- USD27.50
- -14.40%
- 17M
- 288.94k
- 378.73k
- 608M
- 13.36
- -10.80%
Stock News
53 minutes ago
KKR Real Estate Finance Trust Inc. Declares Preferred Stock Dividend
Yahoo
53 minutes ago
Universal Logistics Holdings, Inc. Named a 2023 Supplier of the Year by General Motors
Yahoo
1 hour ago
Carnival Corporation & plc Announces Pricing of €500 Million 5.75% Senior Unsecured Notes Offering for Refinancing and Interest Expense Reduction and Successful Repricing of Senior Secured First Lien Term Loan B Facilities for Interest Expense and Debt Reduction
Yahoo
1 hour ago
UPDATE 1-Teamsters union files charges against PepsiCo with US labor board
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
